Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 50,387,000 | 53,634,000 | 52,716,000 | 51,971,000 | 59,375,000 |
| Cost of Goods | 17,404,000 | 17,345,000 | 16,579,000 | 15,866,000 | 18,983,000 |
| Gross Profit | 32,983,000 | 36,289,000 | 36,137,000 | 36,105,000 | 40,392,000 |
| Operating Expenses | 24,006,000 | 25,200,000 | 25,154,000 | 24,598,000 | 29,612,000 |
| Operating Income | 8,977,000 | 11,089,000 | 10,983,000 | 11,507,000 | 10,780,000 |
| Interest Expense | 655,000 | 704,000 | 683,000 | 724,000 | 751,000 |
| Other Income | -188,000 | 1,887,000 | 507,000 | 453,000 | 526,000 |
| Pre-tax Income | 8,134,000 | 12,272,000 | 10,807,000 | 11,236,000 | 10,555,000 |
| Income Tax | 1,106,000 | 1,545,000 | 1,498,000 | 1,706,000 | 1,483,000 |
| Net Income Continuous | 7,028,000 | 10,727,000 | 9,309,000 | 9,530,000 | 9,072,000 |
| Net Income Discontinuous | 10,766,000 | -447,000 | -17,000 | -147,000 | N/A |
| Minority Interests | 11,000 | 70,000 | 117,000 | 113,000 | 132,000 |
| Net Income | $17,783,000 | $10,210,000 | $9,175,000 | $9,270,000 | $8,940,000 |
| EPS Basic Total Ops | 7.40 | 4.21 | 3.76 | 3.83 | 3.75 |
| EPS Basic Continuous Ops | 2.92 | 4.39 | 3.81 | 3.94 | 3.81 |
| EPS Basic Discontinuous Ops | 4.48 | -0.18 | -0.01 | -0.06 | N/A |
| EPS Diluted Total Ops | 7.29 | 4.13 | 3.70 | 3.79 | 3.70 |
| EPS Diluted Continuous Ops | 2.88 | 4.31 | 3.76 | 3.90 | 3.76 |
| EPS Diluted Discontinuous Ops | 4.42 | -0.18 | -0.01 | -0.06 | N/A |
| EBITDA(a) | $14,448,000 | $11,089,000 | $15,445,000 | $11,507,000 | $16,760,000 |